Kaur P, Chakraborti A, Asea A
Department of Pathology, Scott & White Memorial Hospital and Clinic, The Texas A&M Health Science Center College of Medicine, Temple, TX 76508, USA.
Interdiscip Perspect Infect Dis. 2010;2010:254159. doi: 10.1155/2010/254159. Epub 2010 Mar 11.
Enteroaggregative Escherichia coli (EAEC) are quite heterogeneous category of an emerging enteric pathogen associated with cases of acute or persistent diarrhea worldwide in children and adults, and over the past decade has received increasing attention as a cause of watery diarrhea, which is often persistent. EAEC infection is an important cause of diarrhea in outbreak and non-outbreak settings in developing and developed countries. Recently, EAEC has been implicated in the development of irritable bowel syndrome, but this remains to be confirmed. EAEC is defined as a diarrheal pathogen based on its characteristic aggregative adherence (AA) to HEp-2 cells in culture and its biofilm formation on the intestinal mucosa with a "stacked-brick" adherence phenotype, which is related to the presence of a 60 MDa plasmid (pAA). At the molecular level, strains demonstrating the aggregative phenotype are quite heterogeneous; several virulence factors are detected by polymerase chain reaction; however, none exhibited 100% specificity. Although several studies have identified specific virulence factor(s) unique to EAEC, the mechanism by which EAEC exerts its pathogenesis is, thus, far unknown. The present review updates the current knowledge on the epidemiology, chronic complications, detection, virulence factors, and treatment of EAEC, an emerging enteric food borne pathogen.
肠集聚性大肠杆菌(EAEC)是一类新兴的肠道病原体,种类颇为多样,与全球范围内儿童和成人的急性或持续性腹泻病例相关。在过去十年中,作为水样腹泻(通常为持续性)的病因,它受到了越来越多的关注。EAEC感染是发展中国家和发达国家暴发及非暴发情况下腹泻的重要病因。最近,EAEC被认为与肠易激综合征的发生有关,但这一点仍有待证实。EAEC被定义为一种腹泻病原体,基于其在培养中对HEp-2细胞的特征性集聚性黏附(AA)以及在肠黏膜上形成具有“堆叠砖样”黏附表型的生物膜,这与60 MDa质粒(pAA)的存在有关。在分子水平上,表现出集聚性表型的菌株颇为多样;通过聚合酶链反应检测到几种毒力因子;然而,没有一种表现出100%的特异性。尽管多项研究已经确定了EAEC特有的特定毒力因子,但EAEC发挥其致病作用的机制迄今仍不清楚。本综述更新了关于EAEC这种新兴的食源性肠道病原体在流行病学、慢性并发症、检测、毒力因子和治疗方面的现有知识。